Peptides Panya documents.
Non-GLP-1 peptides users in the Panya community ask about. Each page covers mechanism, typical practice, regulatory status by region, risks, citations, and vendor names worth your own diligence. Panya does not yet route to vendors for these compounds; full scorecards land after legal review.
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein in human gastric juice. Most-studied peptide in the recovery and tendon-healing community. Not approved for human medical use anywhere; sold as a resear...
TB-500 is a synthetic fragment of thymosin beta-4, a naturally-occurring 43-amino-acid peptide. Often stacked with BPC-157 for recovery. Not approved for human use; banned in competitive sport by WADA.
GHK-Cu is a copper-binding tripeptide naturally present in human plasma. Concentration declines with age. Most studied in cosmetic and topical applications. Sold as both a topical cosmetic ingredient and an injectable re...
NAD+ is a coenzyme in every living cell, central to energy metabolism and DNA repair. Levels decline with age. Sold as IV infusion (clinic), subcutaneous injection, oral precursors (NMN, NR), and nasal spray. Best-studie...
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome. Discovered in 2015. Animal data shows insulin-sensitisation and exercise-mimetic effects. Human trials are early; community practice is well ahead of...
Sermorelin is the first 29 amino acids of human growth-hormone-releasing hormone (GHRH). FDA-approved for pediatric GHD until 2008; since then sold compounded for off-label adult anti-aging and recovery use. Less popular...
The most commonly stacked GH-axis pair in current peptide community use. Ipamorelin is a selective ghrelin-receptor agonist that triggers GH release without the appetite or cortisol bumps of older GHRPs. CJC-1295 is a lo...
Tesofensine is a triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinson's disease. Phase 2 trials in obesity showed weight loss roughly twice that of historical anti-...
AOD-9604 is a synthetic 16-amino-acid fragment of human growth hormone, specifically the C-terminal lipolytic region. Marketed for fat loss without the IGF-1 elevation or hyperglycaemia of full HGH. Failed Phase 2b in 20...
Kisspeptin-10 is a 10-amino-acid fragment of the parent kisspeptin peptide, encoded by the KISS1 gene. Acts upstream of GnRH to regulate the hypothalamic-pituitary-gonadal axis. Active human research in fertility and dep...
Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), engineered for resistance to enzymatic breakdown. Originally developed at the University of Arizona for skin photoprotection in fair...
Semax is a synthetic analog of an ACTH fragment (positions 4 to 7), developed at the Russian Academy of Sciences. Approved in Russia for stroke recovery and cognitive impairment. Used internationally as a nootropic. Most...
MK-677 is an orally-active ghrelin receptor agonist developed by Merck in the 1990s. Stimulates GH and IGF-1 release through the same axis ipamorelin uses, but in pill form. Trial data is robust, including a long-term Al...
Dihexa is a small angiotensin IV-derived peptide developed by Joseph Harding's lab as a potential Alzheimer's therapeutic. Acts through the HGF/c-MET pathway to drive spinogenesis. Not approved anywhere; sold in the rese...
ARA-290 is an 11-amino-acid synthetic peptide derived from erythropoietin that targets the innate repair receptor without driving red blood cell production. Has Phase 2 human trial data for small fiber neuropathy. Not ap...